Germline duplication of MYCN predisposes to childhood embryonal tumours

Journal article

BackgroundNeuroblastoma and Wilms tumour (WT) are common childhood embryonal malignancies. Germline 2p24 duplication has been reported in several cases of neuroblastoma and WT, either as part of a larger 2p duplication or as a microduplication involving just 2p24.3. Although the larger duplications involve many genes, including ALK, the microduplications have been localised to a region including MYCN and DDX1.MethodsWe analysed Whole Genome Sequence data from adults and children sequenced for various indications. We utilised a workflow to extract structural and copy number variants, filtered to include duplications or gains of 2 kb-20 Mb, including these loci, followed by manual inspection in IGV. Associations were assessed using Fisher's exact test. Penetrance was estimated by Bayesian calculation of the conditional probability of disease.FindingsAmong 113,431 genomes, there were 6 participants with a microduplication that included the MYCN locus. Of these, two had a diagnosis of WT and one of neuroblastoma. The 2p24.3 microduplication was therefore identified in 3/197 with a definite history of WT/neuroblastoma and 3/113,234 without such a history (p < 0.0001). Penetrance is estimated to be 13%. Twelve participants were identified with a 2p24.3 microduplication that included the DDX1 locus but not MYCN, none of whom received a diagnosis of a childhood embryonal tumour.InterpretationWe have shown that 2p24.3 microduplications that include MYCN predispose to childhood embryonal tumours and should be routinely assessed when WT or neuroblastoma predisposition is suspected. We have also shown that there does not appear to be any increased incidence of childhood tumours when DDX1 alone is duplicated.FundingUCL Great Ormond Street Institute of Child Health Child Health Research CIO PhD Studentship, Brain Tumour Charity, Children with Cancer UK, Great Ormond Street Hospital Children's Charity, Olivia Hodson Cancer Fund, Cancer Research UK and the National Institute for Health Research.

Authors: Taylor, CA; May, P; Stone, TJ; Ahmed, M; Chowdhury, T

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: Elsevier
• Journal: EBioMedicine
• Volume: 124
• Pages: 106132
• Article number: 106132
• Publication date: 2026-01-31
• Acceptance date: 2026-01-09
• DOI: 10.1016/j.ebiom.2026.106132
• EISSN: 2352-3964
• ISSN: 2352-3964
• Pmid: 41621405
• Language: English
• Keywords: Hereditary Cancer Syndromes; Whole Genome Sequencing; Neuroblastoma; Mycn Protein; Wilms Tumour